Letters NICE on statins

Statins for all? A question for society

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4192 (Published 09 July 2014) Cite this as: BMJ 2014;349:g4192
  1. David Barer, geriatrician/stroke physician1
  1. 1South of Tyne and Wear Stroke Collaboration, Sunderland Royal Hospital, Sunderland SR4 7TP, UK
  1. david.barer{at}ncl.ac.uk

The debate about extending the use of statins to those with an (unreliably) estimated 1% annual risk of cardiovascular disease is degenerating into an unseemly row about side effects,1 2 3 largely promoted by the tabloid press on one side and drug companies on the other. This is a dispute that the medical profession should keep out of, at least until the relevant evidence is …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe